These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9459352)

  • 1. Ecarin Clotting Time: a predictive coagulation assay for the antithrombotic activity of argatroban in the rat.
    Berry CN; Lunven C; Girardot C; Lechaire I; Girard D; Charles MC; Ferrari P; O'Brien DP
    Thromb Haemost; 1998 Jan; 79(1):228-33. PubMed ID: 9459352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of a sub-cutaneously administered novel mixed micellar formulation of argatroban in rat and rabbit models of venous thrombosis.
    Berry CN; Visconte C; Lecoffre C; Lochot S; Girard D
    Thromb Haemost; 2000 Aug; 84(2):286-90. PubMed ID: 10959702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
    Berry CN; Girard D; Lochot S; Lecoffre C
    Br J Pharmacol; 1994 Dec; 113(4):1209-14. PubMed ID: 7889274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
    Berry CN; Girard D; Girardot C; Lochot S; Lunven C; Visconte C
    Semin Thromb Hemost; 1996; 22(3):233-41. PubMed ID: 8836007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time.
    Sato K; Kawasaki T; Hisamichi N; Taniuchi Y; Hirayama F; Koshio H; Matsumoto Y
    Br J Pharmacol; 1998 Jan; 123(1):92-6. PubMed ID: 9484858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin (fragmin) and thrombin active-site inhibitor (argatroban) compared in experimental arterial and venous thrombosis and bleeding time.
    Schumacher WA; Heran CL; Steinbacher TE
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):19-25. PubMed ID: 8797131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant activity and pharmacokinetic properties of a sub-cutaneously administered mixed micellar formulation of argatroban in experimental animals.
    Berry CN; Lunven C; Lecoffre C; Lainée P; O'Connor SE; André F; Roger B; Garrigou-Gadenne D; Rouchouse A; Roome NO; Vivan N
    Thromb Haemost; 2000 Aug; 84(2):278-85. PubMed ID: 10959701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation laboratory testing in patients treated with argatroban.
    Walenga JM; Fasanella AR; Iqbal O; Hoppensteadt DA; Ahmad S; Wallis DE; Bakhos M
    Semin Thromb Hemost; 1999; 25 Suppl 1():61-6. PubMed ID: 10357154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.
    Duval N; Lunven C; O'Brien DP; Grosset A; O'Connor SE; Berry CN
    Br J Pharmacol; 1996 Jun; 118(3):727-33. PubMed ID: 8762100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
    Pehrsson S; Johansson K; Kjaer M; Elg M
    Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
    Cho JH; Yun CH; Seo HS; Koga T; Dan T; Koo BA; Kim HY
    Thromb Haemost; 2001 Dec; 86(6):1512-20. PubMed ID: 11776321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.
    Gustafsson D; Elg M; Lenfors S; Börjesson I; Teger-Nilsson AC
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):69-79. PubMed ID: 8845466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation with argatroban for elective percutaneous coronary intervention: population pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of coagulation parameters.
    Akimoto K; Klinkhardt U; Zeiher A; Niethammer M; Harder S
    J Clin Pharmacol; 2011 Jun; 51(6):805-18. PubMed ID: 20663996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
    Imura Y; Stassen JM; Collen D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
    Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
    Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models.
    Peternel L; Stegnar M; Drevensek G; Budihna MV; Bozic M; Zega A; Stalc A; Cerne M; Urleb U
    Thromb Haemost; 2005 Mar; 93(3):437-42. PubMed ID: 15735792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries.
    Tomaru T; Nakamura F; Aoki N; Sakamoto Y; Omata M; Uchida Y
    Heart Vessels; 1996; 11(3):133-44. PubMed ID: 8897062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis.
    Heran C; Morgan S; Kasiewski C; Bostwick J; Bentley R; Klein S; Chu V; Brown K; Colussi D; Czekaj M; Perrone M; Leadley R
    Eur J Pharmacol; 2000 Feb; 389(2-3):201-7. PubMed ID: 10688985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.
    Santos JC; Mesquita JM; Belmiro CL; da Silveira CB; Viskov C; Mourier PA; Pavão MS
    Thromb Res; 2007; 121(2):213-23. PubMed ID: 17482241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.